Inogen Inc (INGN)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO:
Scott Wilkinson
Employees:
285
326 BOLLAY DRIVE, GOLETA, CA 93117
805-562-0500

Inogen, Inc. operates as a medical technology company. It develops, manufactures and markets innovative portable oxygen concentrators which are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Data derived from most recent annual or quarterly report
Market Cap 720.836 Million Shares Outstanding22.611 Million Avg 30-day Volume 257.286 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.54
Price to Revenue4.3378 Debt to Equity0.0 EBITDA12.825 Million
Price to Book Value3.2698 Operating Margin-4.46 Enterprise Value931.817 Million
Current Ratio5.583 EPS Growth-1.365 Quick Ratio4.896
1 Yr BETA 1.0308 52-week High/Low 82.35 / 31.1 Profit Margin-1.8513
Operating Cash Flow Growth-8.4363 Altman Z-Score7.1952 Free Cash Flow to Firm 7.419 Million
View SEC Filings from INGN instead.

View recent insider trading info

Funds Holding INGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INGN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TAYLOR BRENTON EVP, ENGINEERING

  • Officer
70,577 2021-09-28 13

HUGGENBERGER RAYMOND

  • Director
29,389 2021-09-15 6

BAUERLEIN ALISON EVP, FINANCE, & CFO

  • Officer
9,152 2021-09-01 14

SANFORD BART BEN EVP, OPERATIONS

  • Officer
7,561 2021-09-01 4

GLEZER STANISLAV EVP, CHIEF MEDICAL OFFICER

  • Officer
12,298 2021-08-09 2

SOMER JASON EVP, GEN. COUNSEL & SECRETARY

  • Officer
9,223 2021-08-09 2

NOVO HOLDINGS A/S

  • 10% Owner
No longer subject to file 2021-06-02 2

MORA ELIZABETH

  • Director
2,754 2021-05-24 2

GREER R SCOTT

  • Director
60,478 2021-05-10 2

MCFARLAND LOREN L

  • Director
20,108 2021-05-10 2

ANDERSON RAY BENJAMIN M

  • Director
15,291 2021-05-10 1

LUKATCH HEATH

  • Director
12,775 2021-05-10 1

RIDER HEATHER D.

  • Director
13,775 2021-05-10 1

MIRANDA KRISTEN

  • Director
3,889 2021-05-10 3

PARR GEORGE J CHIEF COMMERCIAL OFFICER

  • Officer
18,015 2021-05-07 2

MYERS BYRON EVP, MARKETING

  • Officer
37,327 2021-03-15 3

SHABSHAB NABIL CEO AND PRESIDENT

  • Officer
  • Director
33,872 2021-03-01 3

RETTERER ARRON EVP, SALES

  • Officer
3,763 2021-03-01 1

WILKINSON SCOTT PRESIDENT AND CEO

  • Officer
  • Director
30,737 2020-12-01 1

SCRIBNER MATT

  • FORMER OFFICER
No longer subject to file 2018-09-17 0

BEARDSLEY SCOTT

  • Director
0 2017-01-01 0

PETERSEN TIMOTHY

  • FORMER DIRECTOR
No longer subject to file 2015-08-24 0

VERSANT VENTURES II LLC

VERSANT VENTURE CAPITAL II, LP

VERSANT SIDE FUND II, LP

VERSANT AFFILIATES FUND II-A, LP

ATWOOD BRIAN G

LINK WILLIAM J PHD

MILDER DONALD B

COLELLA SAMUEL D

JAFFE ROSS A MD

ROBERTSON REBECCA B

  • 10% Owner
No longer subject to file 2015-01-06 0

VERSANT VENTURES II LLC

VERSANT VENTURE CAPITAL II, LP

VERSANT SIDE FUND II, LP

VERSANT AFFILIATES FUND II-A, LP

ROBERTSON REBECCA B

BOLZON BRADLEY J PHD

WARDEN CHARLES M

LUBASH BARBARA N

  • 10% Owner
No longer subject to file 2015-01-06 0

VERSANT VENTURES II LLC

VERSANT VENTURE CAPITAL II, LP

VERSANT SIDE FUND II, LP

VERSANT AFFILIATES FUND II-A, LP

ATWOOD BRIAN G

LINK WILLIAM J PHD

MILDER DONALD B

COLELLA SAMUEL D

JAFFE ROSS A MD

  • 10% Owner
3,063,269 2014-11-05 0

VERSANT VENTURES II LLC

VERSANT VENTURE CAPITAL II, LP

VERSANT SIDE FUND II, LP

VERSANT AFFILIATES FUND II-A, LP

BOLZON BRADLEY J PHD

WARDEN CHARLES M

LUBASH BARBARA N

  • 10% Owner
3,409,704 2014-10-24 0

VERSANT VENTURES II LLC

VERSANT VENTURE CAPITAL II, LP

VERSANT SIDE FUND II, LP

VERSANT AFFILIATES FUND II-A, LP

ATWOOD BRIAN G

LINK WILLIAM J PHD

LUBASH BARBARA N

MILDER DONALD B

COLELLA SAMUEL D

JAFFE ROSS A MD

  • 10% Owner
3,428,886 2014-10-09 0

VERSANT VENTURES II LLC

VERSANT VENTURE CAPITAL II, LP

VERSANT SIDE FUND II, LP

VERSANT AFFILIATES FUND II-A, LP

BOLZON BRADLEY J PHD

ROBERTSON REBECCA B

WARDEN CHARLES M

  • 10% Owner
3,414,351 2014-10-09 0

ARBORETUM VENTURES II LP

ARBORETUM VENTURES 1, LLC

ARBORETUM INVESTMENT MANAGER, LLC

ARBORETUM INVESTMENT MANAGER IIA, LLC

ARBORETUM VENTURES 1-A, LLC

ARBORETUM VENTURES 11A LP

ARBORETUM INVESTMENT MANAGER II, LLC

GARFINKLE JAN L.

  • 10% Owner
No longer subject to file 2014-10-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INOGEN INC INGN 2021-11-30 21:15:04 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 20:45:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 20:15:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 19:45:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 19:15:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 18:45:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 18:15:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 17:45:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 17:15:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 16:45:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 16:15:02 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 15:45:03 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 15:15:04 UTC -0.1918 0.2618 850000
INOGEN INC INGN 2021-11-30 14:45:02 UTC -0.18 0.25 850000
INOGEN INC INGN 2021-11-30 14:15:03 UTC -0.18 0.25 850000
INOGEN INC INGN 2021-11-30 13:45:03 UTC -0.18 0.25 850000
INOGEN INC INGN 2021-11-30 13:15:03 UTC -0.18 0.25 850000
INOGEN INC INGN 2021-11-30 12:45:03 UTC -0.18 0.25 850000
INOGEN INC INGN 2021-11-29 22:15:03 UTC -0.18 0.25 950000
INOGEN INC INGN 2021-11-29 21:45:03 UTC -0.18 0.25 950000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund INGN -15.0 shares, $-774.9 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund INGN -7.0 shares, $-361.62 2020-03-31 N-PORT

Elevate your investments